Vimarsana
Biggest News Aggregation in the World

Page 33 - Access Pathway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Access Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Access Pathway Today - Breaking & Trending Today

Soligenix Receives Japanese Patent for Improved Production of Synthetic Hypericin Composition - Vimarsana News

Soligenix Receives Japanese Patent for Improved Production of Synthetic Hypericin Composition

Soligenix Receives Japanese Patent for Improved Production of Synthetic Hypericin Composition Active Ingredient in HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma News provided by Share this article Share this article PRINCETON, N.J., May 20, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Japan Patent Office has allowed the patent application titled "Systems and Methods for Pr...

NVIT building "culturally safe" healthcare practices - Vimarsana News

NVIT building "culturally safe" healthcare practices

  Those looking to enter the healthcare field can begin their journey through a variety of programs at Nicola Valley Institute of Technology (NVIT), BC’s premier indigenous post-secondary institute. “We have three programs running,” explained Ivy McRae, HCA Program Coordinator. “We have the Access to Practical Nursing which is a bridging program into Practical Nursing; we have a healthcare aide program we are offering in the fall, and right now we have the HCAP program, which is the Healthcare Access Pathway, and that one is in partnership with Interior Health.” The Healthcare Acce...

Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results - Vimarsana News

Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results

Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results News provided by Share this article Share this article PRINCETON, N.J., May 17, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended March 31, 2021. "This year continues to be an exciting year of progress for Soligenix," stated Christopher J. Schabe...

NICE steps into the future - Vimarsana News

NICE steps into the future

NICE steps into the future 20th April 2021 Healthcare has changed dramatically since the National Institute of Health and Care Excellence (NICE) was established 22 years ago. We’ve seen incredible advancements in treatments for patients in all disease areas, from cancer and heart disease to genetic conditions, and the UK’s world-renowned life sciences sector continues to provide scientific breakthroughs that improve our understanding of diseases and how best to treat them. It’s against this backdrop, and in the wake of the COVID-19 pandemic, that NICE has launched a new five-year strate...

Mother's heartbreaking four-year fight to get "too bright" daughter support for autism - Vimarsana News

Mother's heartbreaking four-year fight to get "too bright" daughter support for autism

Mother's heartbreaking four-year fight to get "too bright" daughter support for autism Kathryn Jacobs has done whatever she can to help her daughter - but it's still not enough to get her an assessment 06:00, 21 JAN 2021 Updated The video will auto-play soon8Cancel Play now Sign up to the Grimsby Live newsletter for daily updates and breaking newsInvalid EmailSomething went wrong, please try again later. Sign up here! When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services w...